title: Stimulation of prostaglandin E2 production by 12-O-tetradecanoylphorbol 13-acetate (TPA)-type and non-TPA-type tumor promoters in macrophages and its inhibition by cycloheximide.
abstract: The effects of TPA (12-O-tetradecanoylphorbol 13-acetate)-type and non-TPA-type tumor promoters on prostaglandin E2 production by peritoneal macrophages of rats were examined. Among the TPA-type tumor promoters, aplysiatoxin was most potent in stimulating prostaglandin E2 production followed by dihydroteleocidin B, teleocidin, TPA and debromoaplysiatoxin. Prostaglandin E2 production by aplysiatoxin treatment was stimulated at doses up to 0.1 ng/ml. Palytoxin, a non-TPA-type tumor promoter, also stimulated both prostaglandin E2 production and the release of radioactivity from [3H]arachidonic acid-labeled macrophages. However, the dose required for the expression of these effects by palytoxin was up to 3 pg/ml. It was suggested that the tumor promoters are associated with the activity to stimulate arachidonic acid metabolism, irrespective of their type. Cycloheximide, a protein synthesis inhibitor, inhibited both prostaglandin E2 production and the release of radioactivity from prelabeled macrophages stimulated either by the TPA-type tumor promoters or by the non-TPA-type tumor promoter. It is possible that the tumor promoters may induce the synthesis of some proteins responsible for the stimulation of arachidonate metabolism.
authors.forename: K
authors.initials: K
authors.lastname: Ohuchi
authors.forename: M
authors.initials: M
authors.lastname: Watanabe
authors.forename: K
authors.initials: K
authors.lastname: Yoshizawa
authors.forename: S
authors.initials: S
authors.lastname: Tsurufuji
authors.forename: H
authors.initials: H
authors.lastname: Fujiki
authors.forename: M
authors.initials: M
authors.lastname: Suganuma
authors.forename: T
authors.initials: T
authors.lastname: Sugimura
authors.forename: L
authors.initials: L
authors.lastname: Levine
mesh_terms: D000178:Acrylamides; D000818:Animals; D002273:Carcinogens / Q000494:pharmacology*; D003064:Cnidarian Venoms / Q000494:pharmacology; D003513:Cycloheximide / Q000494:pharmacology*; D015232:Dinoprostone; D008235:Lyngbya Toxins / Q000494:pharmacology; D008264:Macrophages / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D010704:Phorbols / Q000494:pharmacology*; D011458:Prostaglandins E / Q000096:biosynthesis*; D051381:Rats; D011919:Rats, Inbred Strains; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology*; D000095702:Polyether Toxins
chemical_list: D000178:Acrylamides; D002273:Carcinogens; D003064:Cnidarian Venoms; D003513:Cycloheximide; D015232:Dinoprostone; D008235:Lyngbya Toxins; D010704:Phorbols; D011458:Prostaglandins E; D013755:Tetradecanoylphorbol Acetate; C022176:teleocidins; C006610:aplysiatoxin; C010272:palytoxin; D000095702:Polyether Toxins